Physician profile
Dylan Stevens
NPI 1316442114
$2,519.77
in general payments reported to CMS, 2019-2025
10 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.72 · 2023: $218 · 2024: $1,895 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $999.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $1,685.78 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Alcon Vision LLC | $481.93 | 2023-2025 | Clareon, Unity, Eysuvis |
| Abbvie INC. | $94.77 | 2023-2024 | Lumigan, Alphagan P |
| Tarsus Pharmaceuticals, INC. | $63.46 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $55.35 | 2025 | Vevye |
| Dompe US, INC. | $26.14 | 2025 | Oxervate |
| Bausch & Lomb Americas INC. | $24.39 | 2024 | Miebo, Xiidra |
| Glaukos Corporation | $23.67 | 2023 | |
| Sun Pharmaceutical Industries INC. | $22.90 | 2023 | Cequa |
| Oyster Point Pharma, INC. | $20.66 | 2024 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.